Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations and Comprehensive Income (Loss)

v3.25.1
Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses:    
Research and development $ 10,637,976 $ 7,883,165
General and administrative 6,189,502 6,379,568
Total operating expenses 16,827,478 14,262,733
Loss from operations (16,827,478) (14,262,733)
Other income (expense):    
Change in fair value of financial instruments 22,581,477 866,738
Interest expense (76,775) (201,390)
Other income 626,184 384,903
Loss on issuance of common shares, warrants, and pre-funded warrants in July 2024 PIPE (3,524,535)  
Total other income (expense), net 19,606,351 1,050,251
Net income (loss) 2,778,873 (13,212,482)
Other comprehensive income (loss)    
Foreign currency translation adjustment   (175,815)
Comprehensive income (loss) $ 2,778,873 $ (13,212,482)
Net income (loss) per share, basic $ 0.11 $ (1.07)
Net income (loss) per share, diluted $ 0.11 $ (1.07)
Weighted-average shares outstanding of common shares, basic 25,919,965 12,292,707
Weighted-average shares outstanding of common shares, diluted 26,461,731 12,292,707